Physician profile
Jenna Wayne
NPI 1598250755
$1,326.53
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $240 · 2021: $108 · 2022: $429 · 2023: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $205.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $261.57 | 2022-2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $220.21 | 2020-2023 | Cequa |
| Novartis Pharmaceuticals Corporation | $160.13 | 2021-2023 | |
| Johnson & Johnson Vision Care, INC. | $151.89 | 2019-2023 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.00 | 2020 | |
| Optovue, INC. | $101.40 | 2019 | |
| Biotissue Holdings INC. | $96.63 | 2022 | |
| Aerie Pharmaceuticals, INC. | $90.68 | 2019 | |
| Eyevance Pharmaceuticals LLC | $49.01 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $38.98 | 2022 | |
| Alcon Vision LLC | $18.68 | 2022 | |
| Allergan, INC. | $12.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Wayne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.